Noah Goodman, Chief Business Officer: Kymera Therapeutics KYMR Sell · Filed 06/22

Trade details

Type: Insider sale
Amount: $247,500
Shares · price: 2,500 sh · $99.00 a share
Held after: 50,195.44 sh
Stock: Kymera Therapeutics KYMR
Person: Noah GoodmanChief Business Officer
Trade date: 26/06/22
Filed: 26/06/22
Days to filing: 0 days

Sold 4.7% of holdings

Share of holding sold: 4.7%

Kymera Therapeutics trades, last 26 weeks

What else happened in Kymera Therapeutics around then

Filed or reported within 30 days of the trade day · 05/23~07/22

Noah Goodman's recent trades

Noah GoodmanChief Business Officer
Planned sale10b5-1 planKymera Therapeutics
Planned sale10b5-1 plan
Kymera Therapeutics
KYMR
$388.6K
3,389 sh
$388.6K
Filed 07/01
Traded 07/01
Noah GoodmanChief Business Officer
Sell10b5-1 planKymera Therapeutics
Sell10b5-1 plan
Kymera Therapeutics
KYMR
$297.5K
2,500 sh
$297.5K
Filed 06/25
Traded 06/25
Noah GoodmanChief Business Officer
Sell10b5-1 planKymera Therapeutics
Sell10b5-1 plan
Kymera Therapeutics
KYMR
$272.5K
2,500 sh
$272.5K
Filed 06/25
Traded 06/25
Noah GoodmanChief Business Officer
Planned sale10b5-1 planKymera Therapeutics
Planned sale10b5-1 plan
Kymera Therapeutics
KYMR
$499.4K
5,000 sh
$499.4K
Filed 06/25
Traded 06/25
Noah GoodmanChief Business Officer
Planned sale10b5-1 planKymera Therapeutics
Planned sale10b5-1 plan
Kymera Therapeutics
KYMR
$226.1K
2,500 sh
$226.1K
Filed 06/22
Traded 06/22